OpenURL Connection Search

Select item for more details and to access through your institution.

Radiological imaging in acute ischaemic stroke.
Published in:
European Journal of Neurology, 2016, v. 23, p. 8, doi. 10.1111/ene.12849
By:
- Kurz, K. D.;
- Ringstad, G.;
- Odland, A.;
- Advani, R.;
- Farbu, E.;
- Kurz, M. W.
Publication type:
Article
Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma.
Published in:
1992
By:
- Advani, Ranjana;
- Chao, Nelson J.;
- Horning, Sandra J.;
- Blume, Karl G.;
- Ahn, David K.;
- Lamborn, Kathleen R.;
- Fleming, Nancy C.;
- Bonnem, Eric M.;
- Greenberg, Peter L.;
- Advani, R;
- Chao, N J;
- Horning, S J;
- Blume, K G;
- Ahn, D K;
- Lamborn, K R;
- Fleming, N C;
- Bonnem, E M;
- Greenberg, P L
Publication type:
journal article
The Pichiapastoris Dihydroxyacetone Kinase is a PTSl -containing, but Cytosolic, Protein that is Essential for Growth on Methanol
Published in:
Yeast, 1998, v. 14, n. 8, p. 759
By:
- Luers, G. H.;
- Advani, R.;
- Wenzel, T.;
- Subramani, S.
Publication type:
Article
Targeting CD40 in Waldenström's macroglobulinemia.
Published in:
2009
By:
- Lee M;
- Advani R
Publication type:
Journal Article
EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis.
Published in:
Rhinology, 2017, v. 55, n. 3, p. 202, doi. 10.4193/Rhin17.028
By:
- Hellings, P. W.;
- Akdis, C. A.;
- Bachert, C.;
- Bousquet, J.;
- Pugin, B.;
- Adriaensen, G.;
- Advani, R.;
- Agache, I.;
- Anjo, C.;
- Anmolsingh, R.;
- Annoni, E.;
- Bieber, T.;
- Bizaki, A.;
- Braverman, I.;
- Callebaut, I.;
- Vizuete, J. A. Castillo;
- Chalermwatanachai, T.;
- Chmielewski, R.;
- Cingi, C.;
- Cools, L.
Publication type:
Article
Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report.
Published in:
2003
By:
- Nguyen, D. D.;
- Loo, B. W.;
- Tillman, G.;
- Natkunam, Y.;
- Cao, T. M.;
- Vaughan, W.;
- Dorfman, R. F.;
- Goffinet, D. R.;
- Jacobs, C. D.;
- Advani, R. H.;
- Loo, B W Jr
Publication type:
journal article
Pregnancy induced hemolytic anemia: an unexplained entity.
Published in:
2001
By:
- Kumar, R.;
- Advani, A. R.;
- Sharan, J.;
- Basharutallah, M. S.;
- Al-Lumai, A. S.
Publication type:
journal article
Brentuximab vedotin does not cause clinically relevant QTc interval prolongation in patients with CD30-positive hematologic malignancies.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 1, p. 241, doi. 10.1007/s00280-013-2192-z
By:
- Han, T.;
- Chen, R.;
- Advani, R.;
- Berryman, R.;
- Smith, S.;
- Forero-Torres, A.;
- Rosenblatt, J.;
- Smith, M.;
- Zain, J.;
- Hunder, N.;
- Engert, A.
Publication type:
Article
Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes.
Published in:
2015
By:
- Pfeifer, M;
- Zheng, B;
- Erdmann, T;
- Koeppen, H;
- McCord, R;
- Grau, M;
- Staiger, A;
- Chai, A;
- Sandmann, T;
- Madle, H;
- Dörken, B;
- Chu, Y-W;
- Chen, A I;
- Lebovic, D;
- Salles, G A;
- Czuczman, M S;
- Palanca-Wessels, M C;
- Press, O W;
- Advani, R;
- Morschhauser, F
Publication type:
journal article
Wake-up stroke-Amendable for thrombolysis-like stroke with known onset time?
Published in:
Acta Neurologica Scandinavica, 2017, v. 136, n. 1, p. 4, doi. 10.1111/ane.12686
By:
- Kurz, M. W.;
- Advani, R.;
- Behzadi, G. N.;
- Eldøen, G.;
- Farbu, E.;
- Kurz, K. D.
Publication type:
Article
THE PROGNOSTIC IMPACT OF CLINICAL FACTORS AND IMMUNOARCHITECTURAL PATTERNS FOR NODULAR LYMPHOCYTE‐PREDOMINANT HODGKIN LYMPHOMA: AN INTERNATIONAL STUDY BY GLOW.
Published in:
Hematological Oncology, 2023, v. 41, p. 100, doi. 10.1002/hon.3163_62
By:
- Binkley, M. S.;
- Flerlage, J. E;
- Borchmann, P.;
- Fuchs, M.;
- Hartmann, S.;
- Eich, H. T.;
- Savage, K. J.;
- Lo, A.;
- Skinnider, B.;
- Akhtar, S.;
- Rauf, M. S.;
- Maghfoor, I.;
- Pinnix, C. C.;
- Steiner, R.;
- Milgrom, S. A.;
- Vega, F.;
- Alomari, M.;
- Zhang, X.;
- Collins, G.;
- Advani, R. H.
Publication type:
Article
Long term outcome of Peripheral T Cell Lymphomas: 10y follow‐up analysis of the International Prospective T Cell Project Network.
Published in:
Hematological Oncology, 2023, v. 41, p. 491, doi. 10.1002/hon.3164_360
By:
- Civallero, M.;
- Advani, R.;
- Horwitz, S.;
- Manni, M.;
- Cabrera, M. E.;
- Vose, J.;
- Spina, M.;
- Hits, F.;
- Nagler, A.;
- Montoto, S.;
- Miranda, E.;
- Skrypets, T.;
- Saenz, M. Perez;
- Priolo, G.;
- Luminari, S.;
- Lymboussakis, A.;
- Pavlovsky, A.;
- Marino, D.;
- Liberati, M.;
- Trotman, J.
Publication type:
Article
Baseline PET Total Metabolic Tumor Volume has a prognostic role in PTCLs—Data from International Prospective T‐Cell Project 2.0.
Published in:
Hematological Oncology, 2023, v. 41, p. 349, doi. 10.1002/hon.3164_250
By:
- Skrypets, T.;
- Chauvie, S.;
- Manni, M.;
- Fallanca, F.;
- Racca, M.;
- Hitz, F.;
- Advani, R.;
- Ramos, C. D.;
- Miranda, E.;
- Tomuleasa, C.;
- Minoia, C.;
- Marino, D.;
- Noyan‐Atalay, F.;
- Stepanishyna, Y.;
- De Maggi, A.;
- Marcheselli, L.;
- Chang, C.;
- Federico, M.;
- Luminari, S.
Publication type:
Article
Mature T and NK cell lymphomas classified according to 2016 WHO classification. A report of 741 cases registered in the International Prospective T‐cell Project 2.0.
Published in:
Hematological Oncology, 2023, v. 41, p. 311, doi. 10.1002/hon.3164_218
By:
- Manni, M.;
- Chiattone, C. S.;
- Prince, M. H.;
- Pavlovsky, A.;
- Tomuleasa, C.;
- Miranda, E.;
- Kriachok, I.;
- Hawkes, E. A.;
- Fiad, L.;
- Hitz, F.;
- Alpdogan, O.;
- Nair, R.;
- Advani, R.;
- Minoia, C.;
- Horwitz, S.;
- Cabrera, M. E.;
- Vose, J. M.;
- Lymboussakis, A.;
- Civallero, M.;
- Skrypets, T.
Publication type:
Article
OUTCOMES OF AUTOLOGOUS TRANSPLANT, ALLOGENEIC TRANSPLANT, AND CAR T CELL THERAPY IN TP53 ALTERED MANTLE CELL LYMPHOMA: A MULTI‐INSTITUTION RETROSPECTIVE ANALYSIS.
Published in:
Hematological Oncology, 2023, v. 41, p. 156, doi. 10.1002/hon.3163_103
By:
- Messmer, M.;
- Stack, A.;
- Deng, M.;
- Handorf, E.;
- Kapoor, N.;
- Sawalha, Y.;
- Bock, A. M.;
- Wang, Y.;
- Graf, K.;
- Greenwell, B.;
- Cleveland, J.;
- Advani, R.;
- Herrera, D. Adrianzen;
- Cai, E.;
- Spinner, M.;
- Hassan, A.;
- Rajguru, S.;
- Phillips, M. S.;
- Smith, S. D.;
- Brooks, T.
Publication type:
Article
CLINICAL RESPONSES TO ODRONEXTAMAB (REGN1979): CORRELATION WITH LOSS OF CD20 EXPRESSION AS A POTENTIAL MECHANISM OF RESISTANCE AND BASELINE BIOMARKERS OF TUMOR T CELLS.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.6_2880
By:
- Brouwer‐Visser, J;
- Fiaschi, N;
- Deering, R. P;
- Dhanik, A;
- Cygan, K. J;
- Zhang, W;
- Jeong, S;
- Pourpe, S;
- Boucher, L;
- Hamon, S;
- Topp, M. S;
- Bannerji, R;
- Duell, J;
- Advani, R. H;
- Flink, D. M;
- Chaudhry, A;
- Sirulnik, A;
- Lowy, I;
- Murphy, A. J;
- Weinreich, D. M
Publication type:
Article
SUBTYPES OF MATURE T AND NK CELL LYMPHOMAS ACCORDING TO 2016 WHO CLASSIFICATION. PRELIMINARY REPORT OF THE INTERNATIONAL PROSPECTIVE T‐CELL PROJECT 2.0.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.135_2880
By:
- Federico, M;
- Chiattone, C. S;
- Prince, H. M;
- Pavlovsky, A;
- Manni, M;
- Civallero, M;
- Skrypets, T;
- De Souza, C. A;
- Hawkes, E. A;
- Fiad, L;
- Lymboussakis, A;
- Tomuleasa, C;
- Nair, R;
- Pereira, J;
- Pereyra, P;
- Minoia, C;
- Kryachok, I;
- de Castro, N. S;
- Advani, R. H;
- Luminari, S
Publication type:
Article
RESPONSE TO A+CHP BY CD30 EXPRESSION IN THE ECHELON‐2 TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 281, doi. 10.1002/hon.92_2630
By:
- Illidge, T.;
- Horwitz, S.;
- Iyer, S.;
- Bartlett, N.;
- Kim, W.;
- Tilly, H.;
- Belada, D.;
- Feldman, T.;
- Illés, Á.;
- Jacobsen, E.;
- Hüttmann, A.;
- Zinzani, P.;
- O'Connor, O.A.;
- Trepicchio, W.;
- Miao, H.;
- Rao, S.;
- Onsum, M.;
- Manley, T.;
- Advani, R.
Publication type:
Article
PHASE I/II STUDY OF CHOEP PLUS LENALIDOMIDE AS INITIAL THERAPY FOR PATIENTS WITH STAGE II‐IV PERIPHERAL T‐CELL LYMPHOMA: PHASE II RESULTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 280, doi. 10.1002/hon.91_2630
By:
- Lunning, M.;
- Horwitz, S.;
- Advani, R.;
- Vose, J.;
- Lee, H.;
- Mehta‐Shah, N.;
- Zain, J.;
- Haverkos, B.;
- Lechowicz, M.;
- Moskowitz, A.;
- Heires, P.;
- Lyden, L.;
- Ansell, S.
Publication type:
Article
EXTENDED FOLLOW‐UP OF A PHASE I TRIAL OF IPILIMUMAB, NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN RELAPSED HODGKIN LYMPHOMA: A TRIAL OF THE ECOG‐ACRIN RESEARCH GROUP (E4412).
Published in:
Hematological Oncology, 2019, v. 37, p. 123, doi. 10.1002/hon.83_2629
By:
- Diefenbach, C.S.;
- Hong, F.;
- Ambinder, R.;
- Cohen, J.;
- Robertson, M.;
- David, K.;
- Advani, R.;
- Fenske, T.;
- Barta, S.;
- Palmisano, N.;
- Svoboda, J.;
- Morgan, D.;
- Karmali, R.;
- Kahl, B.;
- Ansell, S.
Publication type:
Article
CLINICAL ACTIVITY OF REGN1979, AN ANTI‐CD20 X ANTI‐CD3 BISPECIFIC ANTIBODY (AB) IN PATIENTS (PTS) WITH (W/) RELAPSED/REFRACTORY (R/R) B‐CELL NON‐HODGKIN LYMPHOMA (B‐NHL).
Published in:
Hematological Oncology, 2019, v. 37, p. 90, doi. 10.1002/hon.58_2629
By:
- Topp, M.S.;
- Arnason, J.;
- Advani, R.;
- Brown, J.R.;
- Allan, J.;
- Ansell, S.;
- O'Brien, S.;
- Chavez, J.;
- Duell, J.;
- Rosenwald, A.;
- Charnas, R.;
- Ambati, S.R.;
- Adriaens, L.;
- Ufkin, M.;
- Zhu, M.;
- Li, J.;
- Gasparini, P.;
- Jankovic, V.;
- Fiaschi, N.;
- Zhang, W.
Publication type:
Article
THE FIRST‐IN‐CLASS ANTI‐CD47 ANTIBODY HU5F9‐G4 + RITUXIMAB INDUCES DURABLE RESPONSES IN RELAPSED/REFRACTORY DLBCL AND INDOLENT LYMPHOMA: INTERIM PHASE 1B/2 RESULTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 89, doi. 10.1002/hon.57_2629
By:
- Advani, R.;
- Bartlett, N.L.;
- Smith, S.M.;
- Roschewski, M.;
- Popplewell, L.;
- Flinn, I.;
- Collins, G.;
- Ghosh, N.;
- LaCasce, A.;
- Asch, A.;
- Kline, J.;
- Kesevan, M.;
- Tran, T.;
- Lynn, J.;
- Huang, J.;
- Agoram, B.;
- Volkmer, J.;
- Takimoto, C.H.;
- Chao, M.P.;
- Mehta, A.
Publication type:
Article
TIPIFARNIB IN RELAPSED OR REFRACTORY ANGIOIMMUNOBLASTIC T‐CELL LYMPHOMA (AITL) AND CXCL12+ PERIPHERAL T‐CELL LYMPHOMA (PTCL): PRELIMINARY RESULTS FROM A PHASE 2 STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 64, doi. 10.1002/hon.32_2629
By:
- Witzig, T.;
- Sokol, L.;
- Kim, W.;
- Foss, F.;
- Jacobsen, E.;
- Cruz Vincente, F.;
- Caballero, D.;
- Advani, R.;
- Roncero Vidal, J.M.;
- Marin‐Niebla, A.;
- Rodriguez Izquierdo, A.;
- Ona Navarrete, R.;
- Terol, M.J.;
- Domingo‐Domenech, E.;
- Rodriguez, M.;
- Piris, M.A.;
- Bolognese, J.;
- Janes, M.R.;
- Burrows, F.;
- Kessler, L.
Publication type:
Article
RESPONSE TO BRENTUXIMAB VEDOTIN BY CD30 EXPRESSION: RESULTS FROM FIVE TRIALS IN PTCL, CTCL, AND B‐CELL LYMPHOMAS.
Published in:
Hematological Oncology, 2019, v. 37, p. 470, doi. 10.1002/hon.149_2631
By:
- Jagadeesh, D.;
- Horwitz, S.;
- Bartlett, N.L.;
- Advani, R.;
- Jacobsen, E.;
- Duvic, M.;
- Gautman, A.;
- Rao, S.;
- Onsum, M.;
- Fanale, M.;
- Kim, Y.
Publication type:
Article
IBRUTINIB MONOTHERAPY PRODUCES LONG‐TERM DISEASE CONTROL IN PREVIOUSLY TREATED WALDENSTROM'S MACROGLOBULINEMIA. FINAL REPORT OF THE PIVOTAL TRIAL (NCT01614821).
Published in:
Hematological Oncology, 2019, v. 37, p. 184, doi. 10.1002/hon.141_2629
By:
- Treon, S.P.;
- Meid, K.;
- Gustine, J.;
- Yang, G.;
- Xu, L.;
- Patterson, C.J.;
- Ghobrial, I.;
- Laubach, J.P.;
- Hunter, Z.R.;
- Dubeau, T.;
- Palomba, L.;
- Advani, R.;
- Castillo, J.J.
Publication type:
Article
BET INHIBITOR RG6146, VENETOCLAX, AND RITUXIMAB IS A HIGHLY ACTIVE REGIMEN IN RELAPSED/REFRACTORY (R/R) DLBCL: INITIAL REPORT OF PHASE 1B SAFETY, BIOMARKER, AND RESPONSE DATA.
Published in:
Hematological Oncology, 2019, v. 37, p. 174, doi. 10.1002/hon.131_2629
By:
- Dickinson, M.;
- Briones Mejjide, J.;
- Herrera, A.F.;
- González Barca, E.;
- Ghosh, N.;
- Cordoba, R.;
- Rutherford, S.C.;
- Advani, R.;
- Bournazou, E.;
- Labriola‐Tompkins, E.;
- Friess, T.;
- Chesne, E.;
- Brouwer‐Visser, J.;
- Lechner, K.;
- Brennan, B.;
- Nueesch, E.;
- De Mario, M.;
- Hutchings, M.
Publication type:
Article
RESPONSE TO A+CHP BY CD30 EXPRESSION IN THE ECHELON‐2 TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 281, doi. 10.1002/hon.92_2630
By:
- Illidge, T.;
- Horwitz, S.;
- Iyer, S.;
- Bartlett, N.;
- Kim, W.;
- Tilly, H.;
- Belada, D.;
- Feldman, T.;
- Illés, Á.;
- Jacobsen, E.;
- Hüttmann, A.;
- Zinzani, P.;
- O'Connor, O.A.;
- Trepicchio, W.;
- Miao, H.;
- Rao, S.;
- Onsum, M.;
- Manley, T.;
- Advani, R.
Publication type:
Article
PHASE I/II STUDY OF CHOEP PLUS LENALIDOMIDE AS INITIAL THERAPY FOR PATIENTS WITH STAGE II‐IV PERIPHERAL T‐CELL LYMPHOMA: PHASE II RESULTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 280, doi. 10.1002/hon.91_2630
By:
- Lunning, M.;
- Horwitz, S.;
- Advani, R.;
- Vose, J.;
- Lee, H.;
- Mehta‐Shah, N.;
- Zain, J.;
- Haverkos, B.;
- Lechowicz, M.;
- Moskowitz, A.;
- Heires, P.;
- Lyden, L.;
- Ansell, S.
Publication type:
Article
EXTENDED FOLLOW‐UP OF A PHASE I TRIAL OF IPILIMUMAB, NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN RELAPSED HODGKIN LYMPHOMA: A TRIAL OF THE ECOG‐ACRIN RESEARCH GROUP (E4412).
Published in:
Hematological Oncology, 2019, v. 37, p. 123, doi. 10.1002/hon.83_2629
By:
- Diefenbach, C.S.;
- Hong, F.;
- Ambinder, R.;
- Cohen, J.;
- Robertson, M.;
- David, K.;
- Advani, R.;
- Fenske, T.;
- Barta, S.;
- Palmisano, N.;
- Svoboda, J.;
- Morgan, D.;
- Karmali, R.;
- Kahl, B.;
- Ansell, S.
Publication type:
Article
CLINICAL ACTIVITY OF REGN1979, AN ANTI‐CD20 X ANTI‐CD3 BISPECIFIC ANTIBODY (AB) IN PATIENTS (PTS) WITH (W/) RELAPSED/REFRACTORY (R/R) B‐CELL NON‐HODGKIN LYMPHOMA (B‐NHL).
Published in:
Hematological Oncology, 2019, v. 37, p. 90, doi. 10.1002/hon.58_2629
By:
- Topp, M.S.;
- Arnason, J.;
- Advani, R.;
- Brown, J.R.;
- Allan, J.;
- Ansell, S.;
- O'Brien, S.;
- Chavez, J.;
- Duell, J.;
- Rosenwald, A.;
- Charnas, R.;
- Ambati, S.R.;
- Adriaens, L.;
- Ufkin, M.;
- Zhu, M.;
- Li, J.;
- Gasparini, P.;
- Jankovic, V.;
- Fiaschi, N.;
- Zhang, W.
Publication type:
Article
THE FIRST‐IN‐CLASS ANTI‐CD47 ANTIBODY HU5F9‐G4 + RITUXIMAB INDUCES DURABLE RESPONSES IN RELAPSED/REFRACTORY DLBCL AND INDOLENT LYMPHOMA: INTERIM PHASE 1B/2 RESULTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 89, doi. 10.1002/hon.57_2629
By:
- Advani, R.;
- Bartlett, N.L.;
- Smith, S.M.;
- Roschewski, M.;
- Popplewell, L.;
- Flinn, I.;
- Collins, G.;
- Ghosh, N.;
- LaCasce, A.;
- Asch, A.;
- Kline, J.;
- Kesevan, M.;
- Tran, T.;
- Lynn, J.;
- Huang, J.;
- Agoram, B.;
- Volkmer, J.;
- Takimoto, C.H.;
- Chao, M.P.;
- Mehta, A.
Publication type:
Article
TIPIFARNIB IN RELAPSED OR REFRACTORY ANGIOIMMUNOBLASTIC T‐CELL LYMPHOMA (AITL) AND CXCL12+ PERIPHERAL T‐CELL LYMPHOMA (PTCL): PRELIMINARY RESULTS FROM A PHASE 2 STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 64, doi. 10.1002/hon.32_2629
By:
- Witzig, T.;
- Sokol, L.;
- Kim, W.;
- Foss, F.;
- Jacobsen, E.;
- Cruz Vincente, F.;
- Caballero, D.;
- Advani, R.;
- Roncero Vidal, J.M.;
- Marin‐Niebla, A.;
- Rodriguez Izquierdo, A.;
- Ona Navarrete, R.;
- Terol, M.J.;
- Domingo‐Domenech, E.;
- Rodriguez, M.;
- Piris, M.A.;
- Bolognese, J.;
- Janes, M.R.;
- Burrows, F.;
- Kessler, L.
Publication type:
Article
RESPONSE TO BRENTUXIMAB VEDOTIN BY CD30 EXPRESSION: RESULTS FROM FIVE TRIALS IN PTCL, CTCL, AND B‐CELL LYMPHOMAS.
Published in:
Hematological Oncology, 2019, v. 37, p. 470, doi. 10.1002/hon.149_2631
By:
- Jagadeesh, D.;
- Horwitz, S.;
- Bartlett, N.L.;
- Advani, R.;
- Jacobsen, E.;
- Duvic, M.;
- Gautman, A.;
- Rao, S.;
- Onsum, M.;
- Fanale, M.;
- Kim, Y.
Publication type:
Article
IBRUTINIB MONOTHERAPY PRODUCES LONG‐TERM DISEASE CONTROL IN PREVIOUSLY TREATED WALDENSTROM'S MACROGLOBULINEMIA. FINAL REPORT OF THE PIVOTAL TRIAL (NCT01614821).
Published in:
Hematological Oncology, 2019, v. 37, p. 184, doi. 10.1002/hon.141_2629
By:
- Treon, S.P.;
- Meid, K.;
- Gustine, J.;
- Yang, G.;
- Xu, L.;
- Patterson, C.J.;
- Ghobrial, I.;
- Laubach, J.P.;
- Hunter, Z.R.;
- Dubeau, T.;
- Palomba, L.;
- Advani, R.;
- Castillo, J.J.
Publication type:
Article
BET INHIBITOR RG6146, VENETOCLAX, AND RITUXIMAB IS A HIGHLY ACTIVE REGIMEN IN RELAPSED/REFRACTORY (R/R) DLBCL: INITIAL REPORT OF PHASE 1B SAFETY, BIOMARKER, AND RESPONSE DATA.
Published in:
Hematological Oncology, 2019, v. 37, p. 174, doi. 10.1002/hon.131_2629
By:
- Dickinson, M.;
- Briones Mejjide, J.;
- Herrera, A.F.;
- González Barca, E.;
- Ghosh, N.;
- Cordoba, R.;
- Rutherford, S.C.;
- Advani, R.;
- Bournazou, E.;
- Labriola‐Tompkins, E.;
- Friess, T.;
- Chesne, E.;
- Brouwer‐Visser, J.;
- Lechner, K.;
- Brennan, B.;
- Nueesch, E.;
- De Mario, M.;
- Hutchings, M.
Publication type:
Article
SAFETY AND EFFICACY OF COMBINATION OF BRENTUXIMAB VEDOTIN AND NIVOLUMAB IN RELAPSED / REFRACTORY HODGKIN LYMPHOMA: a TRIAL OF THE ECOG-ACRIN CANCER RESEARCH GROUP (E4412).
Published in:
Hematological Oncology, 2017, v. 35, p. 84, doi. 10.1002/hon.2437_72
By:
- Diefenbach, C.S.;
- Hong, F.;
- David, K.;
- Cohen, J.;
- Roberston, M.;
- Advani, R.;
- Palmisano, N.;
- Ambinder, R.;
- Kahl, B.;
- Ansell, S.
Publication type:
Article
A PILOT STUDY OF BRENTUXIMAB VEDOTIN AND AVD CHEMOTHERAPY FOLLOWED BY 20 GY INVOLVED-SITE RADIOTHERAPY IN EARLY STAGE, UNFAVORABLE RISK HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 171, doi. 10.1002/hon.2438_30
By:
- Kumar, A.;
- Casulo, C.;
- Advani, R.;
- Budde, E.;
- Barr, P.M.;
- Batlevi, C.L.;
- Chen, R.;
- Constine, L.S.;
- Courtien, A.I.;
- Dandapani, S.V.;
- Drullinsky, P.;
- Friedberg, J.W.;
- Hamlin, P.A.;
- Hoppe, R.T.;
- Matasar, M.J.;
- McArthur, G.N.;
- Miller, S.T.;
- Moskowitz, A.J.;
- Noy, A.;
- Schoder, H.
Publication type:
Article
PHASE I/II CLINICAL TRIAL OF AN ACTIVATED WHOLE TUMOR CELL VACCINE FOLLOWED BY TRANSFER OF IMMUNE T CELLS IN PATIENTS WITH MANTLE CELL LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 207, doi. 10.1002/hon.2438_72
By:
- Frank, M.;
- Khodadoust, M.;
- Chu, M.;
- Kohrt, H.;
- Advani, R.;
- Alizadeh, A.;
- Reddy, S.;
- Maeda, L.;
- Gupta, N.;
- Laport, G.;
- Meyer, E.;
- Miklos, D.;
- Negrin, R.;
- Rezvani, A.;
- Weng, W.;
- Sheehan, K.;
- Czerwinski, D.;
- Faham, M.;
- Okada, A.;
- Moore, H.
Publication type:
Article
PHASE I/II STUDY OF CHOEP PLUS LENALIDOMIDE AS INITIAL THERAPY FOR PATIENTS WITH STAGE II-IV PERIPHERAL T-CELL NON-HODGKIN LYMPHOMA: PHASE I RESULTS FROM THE T-CELL CONSORTIUM.
Published in:
Hematological Oncology, 2017, v. 35, p. 411, doi. 10.1002/hon.2439_190
By:
- Lunning, M.;
- Horwitz, S.;
- Mehta ‐ Shah, N.;
- Moskowitz, A.;
- Advani, R.;
- Beaven, A.;
- Haverkos, B.;
- Lechowicz, M.;
- Oki, Y.;
- Zain, J.;
- Ansell, S.
Publication type:
Article
PRELIMINARY RESULTS FROM AN OPEN-LABEL, PHASE II STUDY OF TIPIFARNIB IN RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 251, doi. 10.1002/hon.2438_115
By:
- Witzig, T.;
- Sokol, L.;
- Jacobsen, E.;
- Advani, R.;
- Mondejar, R.;
- Piris, M.;
- Burrows, F.;
- Melvin, C.;
- Mishra, V.;
- Scholz, C.;
- Gualberto, A.
Publication type:
Article
Nasal Packs for Epistaxis: Predictors of Success.
Published in:
Clinical Otolaryngology, 2020, v. 45, n. 5, p. 659, doi. 10.1111/coa.13555
By:
- Abbas, Y.;
- Abdelkader, M.;
- Adams, M.;
- Addison, A.;
- Advani, R.;
- Ahmed, T.;
- Alexander, V.;
- Alli, B.;
- Alvi, S.;
- Amiraraghi, N.;
- Ashman, A.;
- Balakumar, R.;
- Bewick, J.;
- Bhasker, D.;
- Bola, S.;
- Bowles, P.;
- Campbell, N.;
- Can Guru Naidu, N.;
- Caton, N.;
- Chapman, J.
Publication type:
Article
Solving the trouble when the tooth is double.
Published in:
2010
By:
- Shivayogi, Hugar;
- Sudha, Patil;
- R., Advani Shweta
Publication type:
Case Study

Found: 42